Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cassava Sciences Inc
(NQ:
SAVA
)
12.35
-6.60 (-34.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Mid-Day Market Update: Dow Jumps Over 200 Points; Bill.com Shares Spike Higher
August 27, 2021
Midway through trading Friday, the Dow traded up 0.69% to 35,457.78 while the NASDAQ rose 1.03% to 15,099.70. The S&P also rose, gaining 0.79% to 4,505.38. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
35 Stocks Moving In Friday's Mid-Day Session
August 27, 2021
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential...
Via
Benzinga
Why the Cassava Sciences Bears Are Wrong
August 27, 2021
The stock's been a wild ride for investors all year, and it's dropped about 40% in two days. What's going on, and why am I bullish?
Via
The Motley Fool
Why Cassava Sciences Is Plunging Again Today
August 27, 2021
More red flags are emerging for this troubled Alzheimer's biotech company.
Via
The Motley Fool
Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations
August 27, 2021
The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again.
Via
Investor's Business Daily
Why Cassava Sciences Stock Investors Are Pulling Back
August 27, 2021
The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of...
Via
Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Big Lots Reports Downbeat Profit
August 27, 2021
Following the market opening Friday, the Dow traded up 0.30% to 35,320.11 while the NASDAQ rose 0.27% to 14,986.36. The S&P also rose, gaining 0.33% to 4,484.57. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
63 Biggest Movers From Yesterday
August 27, 2021
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...
Via
Benzinga
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences on Behalf of Cassava Sciences Stockholders and Encourages Investors to Contact the Firm
August 26, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
CASSAVA SHAREHOLDER ALERT
August 26, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm
August 26, 2021
From
The Schall Law Firm
Via
Business Wire
Why Traders Shouldn’t Bargain Hunt in Cassava Stock
August 26, 2021
Wall Street is notorious for its overreactions, but when it comes to SAVA stock's cratering, investors consider other historical precedents.
Via
InvestorPlace
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – SAVA
August 26, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
As Allegations Swirl, Can Investors Still Count on Cassava Sciences Stock?
August 26, 2021
This once-promising biotech is now struggling to stay afloat.
Via
The Motley Fool
Exposures
Product Safety
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
August 26, 2021
It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment.
Via
The Motley Fool
GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends
August 25, 2021
GameStop Corp. (NYSE:GME) continued to be the most-discussed ...
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm
August 25, 2021
From
The Schall Law Firm
Via
Business Wire
54 Biggest Movers From Yesterday
August 26, 2021
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...
Via
Benzinga
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
August 25, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
CASSAVA INVESTOR ALERT
August 25, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
August 25, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
August 25, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
SAVA Stock: Cassava Sciences Sinks Despite Countering Trial Data Allegations
August 25, 2021
Today, investors in Cassava Sciences and SAVA stock are seeing a lot of red, as investors digest a statement of concern filed yesterday.
Via
InvestorPlace
Exposures
Product Safety
Mid-Afternoon Market Update: Dow Rises 100 Points; ScanSource Shares Surge Following Q4 Results
August 25, 2021
Toward the end of trading Wednesday, the Dow traded up 0.30% to 35,470.78 while the NASDAQ rose 0.12% to 15,038.45. The S&P also rose, gaining 0.28% to 4,498.64. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500, Nasdaq Extend Records on Delta Variant Decline
August 25, 2021
The S&P 500 Index and Nasdaq Composite are on the rise midday, extending yesterday's record closes and nabbing fresh intraday highs.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
2 Little-Known Nasdaq Stocks Making Big Moves Wednesday
August 25, 2021
Don't let these companies fly under your radar.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
SAVA Stock: The Allegations That Have Cassava Sciences Sinking Today
August 25, 2021
Shares of SAVA stock are crashing on Wednesday after allegations about Cassava Sciences' Alzheimer's disease treatment are being reviewed.
Via
InvestorPlace
The Law Offices of Frank R. Cruz Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
August 25, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 25, 2021
Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.